Billionaires are funding anti-aging biotech
Tech billionaires are pouring money into research to slow or reverse aging, a story that's part real biotech investment and part conspiracy framing about an immortal elite.
- Jeff Bezos and investor Yuri Milner backed Altos Labs, a cell-reprogramming startup, with $3 billion and recruited top scientists at high salaries.
- Bezos kept his name off the company's public materials, likely to avoid class-warfare backlash tied to his wealth.
- Peter Thiel has funded aggressive anti-aging research and wants to loosen FDA rules to speed therapies to market.
- Tech founder Brian Johnson spends millions a year on his "Blueprint" program, including young-blood plasma transfusions involving his own son.
- The video leans into a darker claim that these treatments are meant only for the rich, then pivots into a long sales pitch for a kimchi supplement.
Outlook: Billionaire money will keep flowing into longevity startups like Altos Labs, but real anti-aging results remain years away and unproven.